Human medicines European public assessment report (EPAR): Naglazyme, galsulfase, Mucopolysaccharidosis VI, Date of authorisation: 23/01/2006, Revision: 14, Status: Authorised
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
